Literature DB >> 13192249

Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat.

C HUGGINS, E V JENSEN, A S CLEVELAND.   

Abstract

In the hypophysectomized albino rat which is protected from contact with steroids in the ration and environment the uterus and vagina are highly atrophic but are sensitive indicators of activity of substances which promote their growth. Both the pituitary growth hormone and certain steroids have the common property of inducing growth of these tissues. The vaginal epithelium consists of 2 layers of cells which differ profoundly in their growth in response to steroids, depending on the molecular structure of these compounds. The differential response to modifications of chemical structures of steroids permits evaluation of the importance of the intramolecular components for the process of growth. The number and site of functional groups, the geometry of the molecule and the state of oxidation are of high importance in determining physiologic activity of steroids in the androstane series; these features are less specific in the estrane series. Side groups at positions C(3) and C(17) are of importance in the promotion of growth by steroids in the androstane series, but these active centers are not equivalent in their physiological influence. As a generalization, hydrogenation of the oxygen function at C(17) (but not at C(3)) and dehydrogenation at critical areas of the ring structure increase the quantitative efficacy of steroids in promoting growth. The position of double bonds and the state of oxidation at both C(3) and C(17) determine the qualitative type of growth-cellular pattern, which a compound in the androstane series induces in the vaginal epithelium.

Entities:  

Keywords:  PITUITARY GLAND/effect of excision; SOMATOTROPIN/effects; STEROIDS/effects; UTERUS; VAGINA

Mesh:

Substances:

Year:  1954        PMID: 13192249      PMCID: PMC2136373          DOI: 10.1084/jem.100.3.225

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Enzymatic formation of 3 alpha-hydroxysteroids.

Authors:  P TALALAY; P I MARCUS
Journal:  Nature       Date:  1954-06-19       Impact factor: 49.962

2.  Estrogenic activity in a commercial animal ration.

Authors:  M X ZARROW; E A LAZO-WASEM; R L SHOGER
Journal:  Science       Date:  1953-11-27       Impact factor: 47.728

3.  Recent trends in the biochemistry of the steroid hormones.

Authors:  S LIEBERMAN; S TEICH
Journal:  Pharmacol Rev       Date:  1953-09       Impact factor: 25.468

4.  Estrogenic activity of isoflavone derivatives extracted and prepared from soybean oil meal.

Authors:  E CHENG; C D STORY; L YODER; W H HALE; W BURROUGHS
Journal:  Science       Date:  1953-08-07       Impact factor: 47.728

5.  Oestrogenic Action of Compounds of the Androsterone-Testosterone Series.

Authors:  R Deanesly; A S Parkes
Journal:  Br Med J       Date:  1936-02-08

6.  Comparative activities of compounds of the androsterone-testosterone series.

Authors:  R Deanesly; A S Parkes
Journal:  Biochem J       Date:  1936-02       Impact factor: 3.857

7.  THE PRODUCTION OF MUCIFICATION OF THE VAGINAL EPITHELIUM OF RODENTS BY THE OESTROUS HORMONE.

Authors:  R K Meyer; W M Allen
Journal:  Science       Date:  1932-01-22       Impact factor: 47.728

8.  Purification and properties of a beta-hydroxysteroid dehydrogenase.

Authors:  P TALALAY; M M DOBSON
Journal:  J Biol Chem       Date:  1953-12       Impact factor: 5.157

  8 in total
  16 in total

1.  Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.

Authors:  L L Zaulyanov; P S Green; J W Simpkins
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

2.  Metabolism of 11-oxygenated steroids. 1. Influence of the A/B ring junction on the reduction of 11-oxo groups.

Authors:  I E BUSH; V B MAHESH
Journal:  Biochem J       Date:  1959-04       Impact factor: 3.857

3.  ACTIVATION OF HYDROGEN TRANSFER BETWEEN PYRIDINE NUCLEOTIDES BY STEROID HORMONES.

Authors:  P Talalay; H G Williams-Ashman
Journal:  Proc Natl Acad Sci U S A       Date:  1958-01       Impact factor: 11.205

4.  Uterine peroxidase as a marker for estrogen action.

Authors:  C R Lyttle; E R DeSombre
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

5.  Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells.

Authors:  H Miyamoto; S Yeh; H Lardy; E Messing; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

6.  17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells.

Authors:  P S Green; J Bishop; J W Simpkins
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

7.  Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.

Authors:  S Dauvois; S M Li; C Martel; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

8.  Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.

Authors:  R Poulin; D Baker; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

9.  The depression of estrone-induced uterine growth by phenolic estrogens with oxygenated functions at positions 6 or 16: the impeded estrogens.

Authors:  C HUGGINS; E V JENSEN
Journal:  J Exp Med       Date:  1955-09-01       Impact factor: 14.307

10.  The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses.

Authors:  William Owens; John Ashby; Jenny Odum; Lesley Onyon
Journal:  Environ Health Perspect       Date:  2003-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.